Skip to content

Clinical trials

Recruiting Glomerulosclerosis, Focal Segmental trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulosclerosis, Focal Segmental Status: Recruiting Country / region: United States Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20151
20201
20211
20225
20232
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Michigan4
Kaneka Medical America LLC2
Northwell Health2
Akebia Therapeutics1
Boehringer Ingelheim1
Dimerix Bioscience Pty Ltd1
Meyer Children's Hospital IRCCS1
National Human Genome Research Institute (NHGRI)1
Sanofi1
Travere Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulosclerosis, Focal Segmental17
Nephrosis, Lipoid10
Glomerulonephritis, Membranous4
Kidney Diseases3
Nephrotic Syndrome3
Proteinuria3
Disease2
Nephritis, Hereditary2
Recurrence2
Edema1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.